Table 1 Concordance between GIS and shallowHRDv2 test on 449 tumor samples from PAOLA-1 patients.

From: Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial

 

ShallowHRDv2

Positive

Negative

NC

GIS

Positive

196

10

1

Negative

15

173

3

NC

17

23

11

  1. NC non-contributive.
Back to article page